Actively Recruiting
Therapeutic Recommendations for Nephroblastoma
Led by French Africa Pediatric Oncology Group · Updated on 2026-03-02
1000
Participants Needed
7
Research Sites
547 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.
CONDITIONS
Official Title
Therapeutic Recommendations for Nephroblastoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Unilateral nephroblastoma tumor
- Tumor not previously treated
- The general health of the child permits treatment
You will not qualify if you...
- Bilateral nephroblastoma tumor
- Previously treated tumor
- Disease too advanced
- Doubt concerning the diagnosis
- Treatment refusal
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle
Ouagadougou, Burkina Faso
Actively Recruiting
2
CHU de Treichville à ABIDJAN
Abidjan, Abidjan Autonomous District, Côte d’Ivoire
Actively Recruiting
3
CUK (Cliniques Universitaires de Kinshasa)
Kinshasa, Democratic Republic of the Congo, BP 12 KIN XI
Actively Recruiting
4
Cliniques Universitaires de Lubumbashi (CUL)
Lubumbashi, Democratic Republic of the Congo, BP 1825
Actively Recruiting
5
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
Antananarivo, Madagascar
Actively Recruiting
6
CHU Gabriel Touré (HGT)
Bamako, Mali
Actively Recruiting
7
Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001
Dakar, Dakar, Senegal
Actively Recruiting
Research Team
B
BRENDA Ms MALLON, MSC
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here